Suggestions
Paris Panayiotopoulos
Partner and member of the Investment Committee - Blackstone Life Sciences
Paris Panayiotopoulos is a prominent figure in the biopharmaceutical industry with over 20 years of experience in both operating and investing roles.1 He is currently a Senior Managing Director in the Blackstone Life Sciences group and a member of its Investment Committee.12
Career Highlights
Leadership Roles::
- Founder and Board Director of AvenCell Therapeutics34
- Founder and Board Director of Anthos Therapeutics14
- Former CEO and President of Ariad Pharmaceuticals (NASDAQ: ARIA)1
- Former Board Member of The Medicines Company (NASDAQ: MDCO)1
- Former President of US and Japan biopharmaceutical businesses at Merck KGaA1
- Former President of the Serono Research and Development Institute1
Investment Experience::
- Joined Blackstone as part of its acquisition of Clarus in December 20181
- Previously served as Operating Partner at Clarus1
Education
- BS in Chemistry and Management Studies from University College London1
- MS from Cranfield Business School in the United Kingdom1
Additional Involvement
Panayiotopoulos has been involved in founding and leading several biotech companies. He previously served as the founding Chairman of Genevant Sciences and FerGene.15 He is also on the Board of Advisors of the non-profit organization Life Science Cares.12
His extensive experience in the biopharmaceutical industry, combined with his leadership roles in various companies, has established Paris Panayiotopoulos as a significant figure in the field of life sciences and biotechnology.
